BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 30, 2009
View Archived Issues
Qiagen's $130M Purchase of DxS a 13X Profit for Investors
LONDON - There was a record return for all the investors in companion diagnostics pioneer DxS Ltd., when the company was acquired last week by Qiagen NV for a total of up to $130 million. (BioWorld International)
Read More
J&J Buys $444M Stake in Crucell; Focus on Flu Vaccine and mAbs
Read More
Repair Qualities of Macrophages, Hope for Muscle Regeneration
Read More
Rhucin Gains Ground as It Nears EMEA Action in HAE
Read More
NicOx Submits Naproxcinod's NDA; Celebrex in Crosshairs
Read More
Abbott Makes $6.6B Cash Bid for Solvay's Drug Unit
Read More
Marinomed, Bioalvo Collaborate on Drug Discoveries from the Sea
Read More
On the March: Vaccines Make it Big After H1N1 Scare
Read More
2009 Vaccine Deals
Read More
CHMP Gives Unanimous Backing for Yondelis in Ovarian Cancer
Read More
Other News To Note
Read More